Detalhe da pesquisa
1.
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells.
Mol Carcinog
; 63(2): 209-223, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37818798
2.
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
Cancer
; 127(19): 3622-3630, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157782
3.
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.
Int J Mol Sci
; 22(22)2021 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830174
4.
PSSV: a novel pattern-based probabilistic approach for somatic structural variation identification.
Bioinformatics
; 33(2): 177-183, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659451
5.
ChIP-BIT: Bayesian inference of target genes using a novel joint probabilistic model of ChIP-seq profiles.
Nucleic Acids Res
; 44(7): e65, 2016 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26704972
6.
Breast cancer cell obatoclax response characterization using passivated-electrode insulator-based dielectrophoresis.
Electrophoresis
; 38(16): 1988-1995, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608427
7.
BMRF-Net: a software tool for identification of protein interaction subnetworks by a bagging Markov random field-based method.
Bioinformatics
; 31(14): 2412-4, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25755273
8.
MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
Mol Cancer
; 13: 239, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25339305
9.
Mathematically Modeling the Effect of Endocrine and Cdk4/6 Inhibitor Therapies on Breast Cancer Cells.
Methods Mol Biol
; 2634: 337-355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074587
10.
Modeling breast cancer proliferation, drug synergies, and alternating therapies.
iScience
; 26(5): 106714, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37234088
11.
Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy.
Redox Biol
; 52: 102304, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413643
12.
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors.
Front Oncol
; 11: 681530, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34277427
13.
Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer.
Cancers (Basel)
; 12(9)2020 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947941
14.
Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition.
J R Soc Interface
; 17(169): 20200339, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842890
15.
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer.
Front Oncol
; 9: 686, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31428575
16.
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities.
Pharmacol Ther
; 191: 65-73, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933034
17.
Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.
Cancer Res
; 78(20): 5723-5728, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120210
18.
MYC-Driven Pathways in Breast Cancer Subtypes.
Biomolecules
; 7(3)2017 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696357
19.
EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer.
Oncotarget
; 8(57): 96865-96884, 2017 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29228577
20.
Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis.
Oncotarget
; 7(1): 308-22, 2016 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26543228